View all titles in the series
Add to Cart

Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics

Sudip Mukherjee


This book provides a detailed overview of cancer theranostics applications of magnetic iron oxide nanoparticles. Their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity are highlighted, along with current examples of clinical trials of magnetic nanoparticles in cancer theranostics, and their future scopes and challenges.

About Editors

Sudip Mukherjee is a postdoctoral research associate at the department of bioengineering at Rice University. His research involves in the development of advanced nano/bio materials for drug delivery in cancer theranostics, immunomodulatory applications in cancer and diabetes, and angiogenesis. He has published more than 36 peer-reviewed research articles, three book chapters and three patents. He serves as an international advisory board member of Materials Research Express journal and also works as a scientific blog writer for RSC's Biomaterials Science.

Table of Contents

Table of Contents

Chapter 1: Introduction

1.1.        Cancer and statistics

1.2.        Conventional therapies for cancer and their limitations

1.3.        Alternative theranostics strategy: Nanomedicine

1.4.        Magnetic nanoparticles and cancer theranostics

Chapter 2: Magnetic nanoparticles: Types, synthesis and characterization

2.1          Common types of magnetic nanomaterials and their synthesis

2.2          Characterization techniques

2.3          Multilayer concept

Chapter 3: Magnetic nanoparticles for cancer diagnostics

3.1.        MRI

3.2.        Multimodal imaging

3.3.        Biosensors

3.4.        Cell labeling

Chapter 4: Magnetic nanoparticles for cancer therapeutics

4.1.        Drug delivery: Chemotherapeutics, Biotherapeutics and Radiotherapeutics

4.2.        Magnetic Hyperthermia

4.3.        Photodynamic therapy

4.4.        Photothermal ablation

4.5.        MNPs as Anticancer agent

4.6.        MNPs in Cancer Immunotherapy

Chapter 5: Safety of Magnetic nanomaterials, Challenges, future scope and Conclusion 

5.1.        Pharmacokinetics, biodistribution, toxicity

5.2.        Targeting

5.3.        Magnetic nanoparticles as FDA approved or in clinical trials

5.4.        Challenges, future scopes and conclusion


Paperback ISBN: 9780750330206

Ebook ISBN: 9781643277851

DOI: 10.1088/2053-2571/ab41ef

Publisher: Morgan & Claypool Publishers

Series: Series in Photomedicine and Biophotonics


« Back